In this study, we synthesized and characterized a GnRHR-targeted NIR fluorescent probe, GnRHa-PEG-Rh760, and demonstrated its specific binding and imaging capabilities for primary tumors, peritoneal metastases, and lymph node metastases in ovarian cancer. This evidence concerns the gene GNRHR and ovarian cancer.